Conditions permitting suppression of stretch-induced and vasoconstrictor tone by basal nitric oxide activity in porcine cerebral artery

British Journal of Pharmacology

Volumn 130, Issue 3, 2000, Pages 567-574

  Wallis, Sarah J ^a   Martin, William ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

5 Hydroxytryptamine; Cerebral artery; Endothelium; Myogenic tone; Nitric oxide; Nitric oxide synthase inhibitor; U46619

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; CURCUMIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PAPAVERINE; SEROTONIN; TETRODOTOXIN;

ANIMAL TISSUE; ARTERY TONE; ARTICLE; BRAIN ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM; MUSCLE STRETCHING; NONHUMAN; PRIORITY JOURNAL; SWINE; VASOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CEREBRAL ARTERIES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; MALE; MUSCLE CONTRACTION; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SEROTONIN; SWINE; VASOCONSTRICTION;

EID: 0034032826     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703351     Document Type: Article

References (33)

1. ALONSO, M.J., SALAICES, M., SANCHEZ-FERRER, C.F. & MARIN, J. (1992). Predominant role of nitric oxide in the relaxation induced by acetylcholine in cat cerebral arteries. J. Pharmacol. Exp. Ther., 261, 12-20.
2. 2 in the mediation of the contractile effect induced by inhibition of nitric oxide synthesis in isolated rat middle cerebral arteries. J. Cereb. Blood Flow Metab., 18, 616-618.
3. BRIAN, J.E. & KENNEDY, R.H. (1993). Modulation of cerebral arterial tone by endothelium-derived relaxing factor. Am. J. Physiol., 264, H1245-H1250.
4. BROUET, I. & OHSHIMA, H. (1995). Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun., 206, 533-540.
5. COCKS, T.M. & ANGUS, J.A. (1983). Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature, 305, 627-630.
6. COHEN, R.A., SHEPHERD, J.T. & VANHOUTTE, P.M. (1983). 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am. J. Physiol., 245, H1077-H1080.
7. CONNOR, H.E. & FENIUK, W. (1989). Influence of the endothelium on contractile effects of 5-hydroxytryptamine and selective 5-HT agonists in canine basilar artery. Br. J. Pharmacol., 96, 170-178.
8. D'ANGELO, G. & MEININGER, G.A. (1994). Transduction mechanisms involved in the regulation of myogenic activity. Hypertension, 23, 1096-1105.
9. FORD-HUTCHINSON, A.W., TAGARI, P., CHING, S.V., ANDERSON, C.A., COLEMAN, J.B. & PETER, C.P. (1993). Chronic leukotriene inhibition in the rat fails to modify the toxicological effects of a cyclo-oxygenase inhibitor. Can. J. Physiol. Pharmacol., 71, 806-810.
10. FURCHGOTT, R.F. (1984). The role of endothelium in the responses of vascular smooth muscle to drugs. Ann. Rev. Pharmacol. Toxicol., 24, 175-197.
11. G-monomethyl L-arginine on the response of the rat anococcygeus to NANC nerve stimulation. Br. J. Pharmacol., 98, 1080-1082.
12. KIM, P., SHIMOKAWA, H. & VANHOUTTE, P.M. (1992). Dietary ω-3 fatty acids and endothelium-dependent responses in porcine cerebral arteries. Stroke, 23, 407-413.
13. G-nitro-L-arginine and L-arginine on regional cerebral blood flow in the cat. J. Physiol., 449, 183-196.
14. LEE, T.J.F., SARWINSKI, S.J., ISHINE, T., LAI, C.C. & CHEN, F.-Y. (1996). Inhibition of cerebral neurogenic vasodilatation by L-glutamine and nitric oxide synthase inhibitors and its reversal by L-citrulline. J. Pharmacol. Exp. Ther., 276, 353-358.
15. LI, C.G. & RAND, M.J. (1989). Evidence for a role of nitric oxide in the neurotransmitter system mediating relaxation of the rat anococcygeus muscle. Clin. Exp. Pharmacol. Physiol., 16, 933-938.
16. MARTIN, W. (1988). Basal release of endothelium-derived relaxing factor. In Relaxing and Contracting Factors. ed. Vanhoutte, P.M. pp. 159-178. Clifton, New Jersey: Humana Press.
17. MARTIN, W., VILLANI, G.M., JOTHIANANDAN, D. & FURCHGOTT, R.F. (1985). Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther., 232, 708-716.
18. MILLER, F.J., DELLSPERGER, K.C. & GUTTERMAN, D.D. (1997). Myogenic constriction of human coronary arterioles. Am. J. Physiol., 273, H257-H264.
19. MILLER, V.M. & VANHOUTTE, P.M. (1985). Endothelial α2-adrenoceptors in canine pulmonary and systemic blood vessels. Eur. J. Pharmacol., 118, 123-129.
20. MINATO, H., HASHIZUME, M., MASUDA, Y. & HOSOKI, K. (1995). Modulation of extraluminally induced vasoconstrictions by endothelium-derived nitric oxide in the canine basilar artery. Arzneim.-Forsch., 45, 675-678.
21. NOZU, K. (1978). Flurbiprofen: highly potent inhibitor of prostaglandin synthesis. Biochem. Biophys. Acta., 529, 493-496.
22. OHLSTEIN, E.H., NAMBI, P., DOUGLAS, S.A., EDWARDS, R.M., GELLAI, M., LAGO, A., LEBER, J.D., COUSINS, R.D., GAO, A., FRAZEE, J.S., PEISHOFF, C.E., BEAN, J.W., EGGLESTON, D.S., ELSHOURBAGY, N.A., KUMAR, C., LEE, J.A., YUE, T.-L., LOUDEN, C., BROOKS, D.P., WEINSTOCK, J., FEUERSTEIN, G., POSTE, G., RUFFOLO, R.R., GLEASON, J.G. & ELLIOTT, J.D. (1994). SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc. Natl. Acad. Sci. U.S.A., 91, 8052-8056.
23. PRADO, R., WATSON, B.D., KULUZ, J. & DIETRICH, W.D. (1992). Endothelium-derived nitric oxide synthase inhibition: effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats. Stroke, 23, 1118-1124.
24. RAJAGOPALAN, S , DUBE, S. & CANTY, J.M. (1995). Regulation of coronary diameter by myogenic mechanisms in arterial microvessels greater than 100 μm in diameter. Am. J. Physiol., 268, H788-H793.
25. REES, D.D., PALMER, R.M.J., SCHULZ, R., HODSON, H.F. & MONCADA, S. (1990). Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101, 746-752.
26. G-nitro-L-arginine methyl ester on the cardiovascular system of the anesthetised rabbit and on the cardiovascular response to thyrotropin-releasing hormone. Br. J. Pharmacol., 109, 1219-1225.
27. SUN, D., MESSINA, E.J., KALEY, G. & KOLLER, A. (1992). Characteristics and origin of myogenic response in isolated mesenteric arterioles. Am. J. Physiol., 263, H1486-H1491.
28. THORIN, E., NGUYEN, T.-D. & BOUTHILLIER, A (1998). Control of vascular tone by endogenous endothelin-1 in human pial arteries. Stroke, 29, 175-188.
29. TODA, N., AYAJIKI, K. & OKAMURA, T. (1993a). Neural mechanism underlying basilar artery constriction by intracisternal L-NNA in anesthetised dogs. Am. J. Physiol., 265, H103-H107.
30. G-nitro-L-arginine in isolated dog and monkey cerebral arteries. Stroke, 24, 1584-1588.
31. TREZISE, D.J., DREW, G.M. & WESTON, A.H. (1992). Analysis of the depressant effect of the endothelium on contractions of rabbit isolated basilar artery to 5-hydroxytryptamine. Br. J. Pharmacol., 106, 587-592.
32. WALLIS, S.J. & MARTIN, W. (1999). Suppression of myogenic and vasoconstrictor tone in porcine cerebral artery by basal nitric oxide activity. Br. J. Pharmacol., 128, 62P.
33. YAMAKAWA, N., OHASHI, M., WAGA, S. & ITOH, T. (1997). Role of endothelium in regulation of smooth muscle membrane potential and tone in the rabbit middle cerebral artery. Br. J. Pharmacol., 121, 1315-1322.